Award recordCONTRACT

GOLDEN STATE MEDICAL SUPPLY, INC.

PIID 36E79725N0018· VA Staff Offices· NAC PHARMACEUTICALS (36E797)· 6505 · DRUGS AND BIOLOGICALS· FY2025· $358,377 net obligations· UEI GQLDJJ8AQNN5· CA

Description

MODIFICATION TO DECREASE FUNDING FOR PRODUCT NOT RECEIVED FOR DELIVERY ORDER FOR METFORMIN WITH GOLDEN STATE MEDICAL SUPPLY FOR THE REPACKAGING PROGRAM.

Base award description: DELIVERY ORDER FOR METFORMIN WITH GOLDEN STATE MEDICAL SUPPLY FOR THE REPACKAGING PROGRAM.

First action · last action
2025-03-04 · 2025-03-26
Transactions
3
First transaction's obligation
$347,130
Base + all options value (sum of deltas)
$358,377
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
36E79720D0036
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$358,424$0Base award · 2025-03-04 · this action $347,130 · running total $347,130Modification P00001 · 2025-03-26 · this action $11,294 · running total $358,424Modification P00002 · 2025-03-26 · this action -$47 · running total $358,377
  • Base2025-03-04+$347,130= $347,130
  • Mod P000012025-03-26+$11,294= $358,424
  • Mod P000022025-03-26-$47= $358,377
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2025-03-04+$347,130$347,130DELIVERY ORDER FOR METFORMIN WITH GOLDEN STATE MEDICAL SUPPLY FOR THE REPACKAGING PROGRAM.
Mod P00001· FUNDING ONLY ACTION2025-03-26+$11,294$358,424MODIFICATION TO INCREASE FUNDING FOR ADDITIONAL PRODUCT RECEIVED FOR DELIVERY ORDER FOR METFORMIN WITH GOLDEN…
Mod P00002· FUNDING ONLY ACTION2025-03-26−$47$358,377MODIFICATION TO DECREASE FUNDING FOR PRODUCT NOT RECEIVED FOR DELIVERY ORDER FOR METFORMIN WITH GOLDEN STATE M…

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI GQLDJJ8AQNN5)

AwardOffice · PSC / listingNet obligationsFY
36E79726D0041NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36E79726D0042NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36E79726D0022NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36E79726D0014NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36E79726D0023NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36E79726D0018NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026

Other recipients under 6505 from NAC PHARMACEUTICALS (36E797) (most recent first)

AwardRecipientOfficeNet obligationsFY
36E79726A0025CHIESI USA INCNAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0024NEUROTECH PHARMACEUTICALS, INCNAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0023TAKEDA PHARMACEUTICALS AMERICA, INC.NAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0022AURINIA PHARMA US INCNAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0021ALEXION PHARMACEUTICALS INCNAC PHARMACEUTICALS (36E797)$0FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36E79725N0018_3600_36E79720D0036_3600 · retrieved 2026-09-26.